Cardiovascular Disease in Children and Adolescents With Chronic Kidney Disease
- PMID: 30413251
- DOI: 10.1016/j.semnephrol.2018.08.002
Cardiovascular Disease in Children and Adolescents With Chronic Kidney Disease
Abstract
The lifespan of children with advanced chronic kidney disease (CKD), although improved over the past 2 decades, remains low compared with the general pediatric population. Similar to adults with CKD, cardiovascular disease accounts for a majority of deaths in children with CKD because these patients have a high prevalence of traditional and uremia-related risk factors for cardiovascular disease. The cardiovascular alterations that cause these terminal events begin early in pediatric CKD. Initially, these act to maintain hemodynamic homeostasis. However, as the disease progresses, these modifications are unable to sustain cardiovascular function in the long term, leading to left ventricular failure, depressed cardiorespiratory fitness, and sudden death. In this review, we discuss the prevalence of the risk factors associated with cardiovascular disease in pediatric patients with CKD, the pathophysiology that stimulates these changes, the cardiac and vascular adaptations that occur in these patients, and management of the cardiovascular risk in these patients.
Keywords: Heart; cardiovascular; children; chronic kidney disease.
Copyright © 2018. Published by Elsevier Inc.
Similar articles
-
Cardiovascular complications in children with chronic kidney disease.Nat Rev Nephrol. 2011 Sep 13;7(11):642-9. doi: 10.1038/nrneph.2011.116. Nat Rev Nephrol. 2011. PMID: 21912426 Review.
-
Renal hypertension and cardiovascular disorder in children with chronic kidney disease.Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):113-7. doi: 10.2298/sarh1402113p. Srp Arh Celok Lek. 2014. PMID: 24684043 Review.
-
Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.Kidney Blood Press Res. 2017;42(3):406-415. doi: 10.1159/000478867. Epub 2017 Jul 7. Kidney Blood Press Res. 2017. PMID: 28689198
-
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.J Am Soc Nephrol. 2016 Mar;27(3):877-86. doi: 10.1681/ASN.2014111111. Epub 2015 Sep 18. J Am Soc Nephrol. 2016. PMID: 26386072 Free PMC article.
-
Pediatric CKD and cardiovascular disease.Cardiovasc Hematol Disord Drug Targets. 2014;14(3):177-84. doi: 10.2174/1871529x14666140401112335. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 24720458 Review.
Cited by
-
Nonlinear association between proteinuria levels and the risk of cardiovascular disease events and all-cause mortality among chronic kidney disease patients.Ren Fail. 2024 Dec;46(1):2310727. doi: 10.1080/0886022X.2024.2310727. Epub 2024 Feb 12. Ren Fail. 2024. PMID: 38345084 Free PMC article.
-
Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives.Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):203-211. doi: 10.1097/MNH.0000000000000952. Epub 2024 Jan 5. Curr Opin Nephrol Hypertens. 2024. PMID: 38193308 Review.
-
Plasma and Urinary Platelet Factor 4 as Biomarkers for Cardiovascular Risk in Children with Chronic Kidney Disease.Biomedicines. 2023 Dec 15;11(12):3318. doi: 10.3390/biomedicines11123318. Biomedicines. 2023. PMID: 38137539 Free PMC article.
-
Should we consider sarcopenia in pediatric patients with chronic kidney disease? A preliminary cross-sectional analysis.Pediatr Nephrol. 2024 Feb;39(2):539-545. doi: 10.1007/s00467-023-06111-9. Epub 2023 Aug 11. Pediatr Nephrol. 2024. PMID: 37566115
-
Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2-5.Pediatr Nephrol. 2023 Aug;38(8):2763-2770. doi: 10.1007/s00467-023-05887-0. Epub 2023 Feb 13. Pediatr Nephrol. 2023. PMID: 36780007
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
